Renaissance Technologies’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
164,200
-13,500
| -8% | -$9.18K | ﹤0.01% | 3283 |
|
|
2025
Q1 | $129K | Sell |
177,700
-118,917
| -40% | -$86.1K | ﹤0.01% | 3154 |
|
|
2024
Q4 | $283K | Buy |
296,617
+30,317
| +11% | +$29K | ﹤0.01% | 3061 |
|
|
2024
Q3 | $210K | Sell |
266,300
-28,700
| -10% | -$22.6K | ﹤0.01% | 3111 |
|
|
2024
Q2 | $280K | Buy |
295,000
+45,554
| +18% | +$43.2K | ﹤0.01% | 2935 |
|
|
2024
Q1 | $269K | Buy |
249,446
+39,746
| +19% | +$42.9K | ﹤0.01% | 3129 |
|
|
2023
Q4 | $115K | Buy |
209,700
+189,000
| +913% | +$104K | ﹤0.01% | 3271 |
|
|
2023
Q3 | $44K | Buy |
20,700
+400
| +2% | +$850 | ﹤0.01% | 3425 |
|
|
2023
Q2 | $53K | Buy |
20,300
+1,500
| +8% | +$3.92K | ﹤0.01% | 3607 |
|
|
2023
Q1 | $60K | Sell |
18,800
-18,300
| -49% | -$58.4K | ﹤0.01% | 3619 |
|
|
2022
Q4 | $100K | Buy |
37,100
+8,600
| +30% | +$23.2K | ﹤0.01% | 3617 |
|
|
2022
Q3 | $83K | Sell |
28,500
-46,800
| -62% | -$136K | ﹤0.01% | 3651 |
|
|
2022
Q2 | $220K | Buy |
+75,300
| New | +$220K | ﹤0.01% | 3611 |
|